人白细胞介素-21及其受体的研究进展 |
| |
引用本文: | 付美兰 徐帆洪. 人白细胞介素-21及其受体的研究进展[J]. 国际生物制品学杂志, 2015, 38(5): 246-249. DOI: 10.3760/cma.j.issn.1673-4211.2015.05.009 |
| |
作者姓名: | 付美兰 徐帆洪 |
| |
作者单位: | 200052 上海生物制品研究所有限责任公司第一研究室 |
| |
摘 要: | 人白细胞介素(interleukin, IL)21(IL-21)是一种由CD4+ T细胞、自然杀伤细胞、17型辅助性T细胞等分泌的I型细胞因子。IL-21受体是一种典型的I型细胞因子受体,在大部分骨髓细胞、淋巴细胞等表面都有表达。IL-21与IL-21受体结合可对机体免疫应答产生广泛的影响。IL-21具有抗肿瘤作用,IL-21与其他细胞因子、抗体、疫苗联用是一种有效的肿瘤治疗方法。
|
关 键 词: | 白细胞介素类 受体 白细胞介素21 免疫调节 肿瘤 治疗应用 |
Development on research of human interleukin-21 and its receptor |
| |
Affiliation: | No.1 Research Laboratory, Shanghai Institute of Biological Products Co. Ltd, Shanghai 200052, China |
| |
Abstract: | Human interleukin-21(IL-21) is a typeⅠcytokine produced by CD4+ T cell, natural killer cell and T helper 17 cell. IL-21 receptor (IL-21R) is a typical type I cytokine receptor, and can be expressed on most of bone marrow cells and lymphocytes. The binding of IL-21 and IL-21R has broad effects on both innate and adaptive immune responses. IL-21 has anti-tumor activity, and the strategy of combining IL-21 with other cytokines, antibodies, and vaccines is an effective and hopeful method on tumor theroputic. |
| |
Keywords: | Interleukins Receptors interleukin-21 Immunomdulation Neoplasms Therapeutic uses |
本文献已被 万方数据 等数据库收录! |
| 点击此处可从《国际生物制品学杂志》浏览原始摘要信息 |
|
点击此处可从《国际生物制品学杂志》下载免费的PDF全文 |